anidulafungin has been researched along with miconazole in 2 studies
| Studies (anidulafungin) | Trials (anidulafungin) | Recent Studies (post-2010) (anidulafungin) | Studies (miconazole) | Trials (miconazole) | Recent Studies (post-2010) (miconazole) |
|---|---|---|---|---|---|
| 568 | 33 | 331 | 2,309 | 238 | 476 |
| Protein | Taxonomy | anidulafungin (IC50) | miconazole (IC50) |
|---|---|---|---|
| Metabotropic glutamate receptor 6 | Homo sapiens (human) | 6.5 | |
| Acetylcholinesterase | Electrophorus electricus (electric eel) | 2.4 | |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 5.314 | |
| Bile salt export pump | Homo sapiens (human) | 10 | |
| Cytochrome P450 1A2 | Mus musculus (house mouse) | 4.55 | |
| Cytochrome P450 1A2 | Rattus norvegicus (Norway rat) | 4.55 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 4.55 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 4.16 | |
| Heme oxygenase 1 | Rattus norvegicus (Norway rat) | 5.8 | |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 2 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 2.939 | |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 4.336 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 3.197 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 3 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.4938 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 3.966 | |
| Adenosine receptor A3 | Homo sapiens (human) | 2.811 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 1.32 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 3.971 | |
| Aromatase | Homo sapiens (human) | 0.6 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.2 | |
| Beta-3 adrenergic receptor | Homo sapiens (human) | 5.482 | |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 3.7 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 7.089 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 2.811 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 3.598 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 3.154 | |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 7.8 | |
| Substance-K receptor | Homo sapiens (human) | 4.839 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 6.247 | |
| Heme oxygenase 2 | Rattus norvegicus (Norway rat) | 5.8 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.939 | |
| Thromboxane-A synthase | Homo sapiens (human) | 0.263 | |
| Histamine H2 receptor | Homo sapiens (human) | 6.75 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 3.046 | |
| Substance-P receptor | Homo sapiens (human) | 6.813 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 3.907 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 5.314 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.778 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.008 | |
| Mu-type opioid receptor | Homo sapiens (human) | 6.059 | |
| D(3) dopamine receptor | Homo sapiens (human) | 3.199 | |
| Delta-type opioid receptor | Homo sapiens (human) | 3.387 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 6.594 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 5.545 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 2.811 | |
| Cholinesterase | Equus caballus (horse) | 5.55 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.701 | |
| Lanosterol 14-alpha demethylase | Homo sapiens (human) | 0.2 | |
| Indoleamine 2,3-dioxygenase 2 | Mus musculus (house mouse) | 6.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eraso, E; Gil-Alonso, S; Jauregizar, N; Marcos-Arias, C; Mateo, E; Quindós, G; Sevillano, E | 1 |
| Abastabar, M; Aghili, SR; Badali, H; Haghani, I; Hedayati, MT; Javidnia, J; Khojasteh, S; Meis, JF; Moazeni, M; Nargesi, S; Nosratabadi, M; Shabanzadeh, S; Shokohi, T; Zaedi, A | 1 |
1 review(s) available for anidulafungin and miconazole
| Article | Year |
|---|---|
Therapeutic tools for oral candidiasis: Current and new antifungal drugs.
Topics: Administration, Intravenous; Administration, Oral; Administration, Topical; Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candidiasis, Oral; Caspofungin; Clotrimazole; Databases, Factual; Drug Interactions; Echinocandins; Fluconazole; Humans; Miconazole; Nitriles; Nystatin; Pyridines; Triazoles | 2019 |
1 other study(ies) available for anidulafungin and miconazole
| Article | Year |
|---|---|
In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillus oryzae; Clotrimazole; Econazole; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Natamycin; Nystatin; Terbinafine; Tolnaftate; Voriconazole | 2022 |